Closing Perspectives

Experts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.

EP: 1.CGM: Redefining Type 2 Diabetes Management

EP: 2.Key Benefits of CGM Technology

EP: 3.CGM's Impact on Clinical Inertia

EP: 4.CGM vs Traditional Monitoring

EP: 5.Understanding CGM Metrics

EP: 6.Health Care System Integration

EP: 7.CGM Coverage and Access

EP: 8.Implementation Barriers

EP: 9.Overcoming Access Challenges

EP: 10.Adoption Strategies

EP: 11.The Metro Nashville Public Schools Initiative

EP: 12.Health Care Quality Impact

EP: 13.Population Outcomes and Return on Value With CGMs

EP: 14.Long-Term Outcomes Assessment

Now Viewing

EP: 15.Closing Perspectives

Video content above is prompted by the following:

1. How do you evaluate the cost-effectiveness of CGM compared to traditional monitoring when considering both clinical and quality outcomes?
2. What: combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations?

Related Videos